Physician profile
Adam P Dicker
NPI 1558383984
$46,182.58
in general payments reported to CMS, 2019-2025
15 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what 88% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,234 · 2020: $17K · 2021: $5,207 · 2022: $6,547 · 2023: $3,381 · 2024: $3,478 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,400 · Travel and Lodging: $2,293 · Food and Beverage: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,400.00 |
| Travel and Lodging | $2,292.77 |
| Food and Beverage | $1,859.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $11,425.00 | 2020-2024 | Erleada |
| Emd Serono, INC. | $10,703.30 | 2019-2020 | |
| Roche Diagnostics Corporation | $8,143.00 | 2020 | |
| Genentech, INC. | $5,878.75 | 2021-2022 | |
| Varian Medical Systems, INC. | $2,600.26 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $1,942.30 | 2021-2025 | Varian Treatment |
| Reflexion Medical, INC. | $1,702.28 | 2023-2024 | Reflexion Medical Radiotherapy System |
| Ion Beam Applications S.A. | $1,500.00 | 2021 | |
| Merck Sharp & Dohme LLC | $1,000.00 | 2019 | |
| Genzyme Corporation | $577.49 | 2019 | |
| Mevion_medical_systems_inc | $529.93 | 2023 | Pts250 |
| Janssen Biotech, INC. | $102.79 | 2019 | |
| Blue Earth Diagnostics | $48.83 | 2023 | |
| Novartis Pharmaceuticals Corporation | $28.65 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Dicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.